–
NRX Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
0
FY25:
0.72
(positive)
Change from FY21 to FY25
millions USD
FY21:
−116
FY22:
−44.3
FY23:
−27.8
FY24:
−18.5
FY25:
−16.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−116
FY22:
−44.6
FY23:
−30.0
FY24:
−23.2
FY25:
−27.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−93.1
FY22:
−39.8
FY23:
−30.2
FY24:
−25.1
FY25:
−28.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−93.1
FY22:
−39.8
FY23:
−30.2
FY24:
−25.1
FY25:
−28.6
All amounts in millions USD